These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4625850)

  • 1. The role of cystography in thio-tepa toxicity.
    Orlin I
    J Urol; 1972 Aug; 108(2):257-8. PubMed ID: 4625850
    [No Abstract]   [Full Text] [Related]  

  • 2. Vesicoureteral reflux in recurrent carcinoma of the bladder--implications for treatment and prognosis.
    Schmidt JD; Jacobo EC; Weinstein SH
    J Urol; 1976 Dec; 116(6):734-6. PubMed ID: 826656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 4. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
    Wescott JW
    J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
    Nissenkorn I; Servadio C; Vilikowski E; Glanz I
    J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
    Horn Y; Eidelman A; Walach N; Ilian M
    J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dibunol and thio-TEPA treatment of bladder tumors].
    Barsel' VA
    Urol Nefrol (Mosk); 1978; (4):27-30. PubMed ID: 98889
    [No Abstract]   [Full Text] [Related]  

  • 10. Unanticipated vesicoureteral reflux: a possible sequela of long-term thio-tepa instillations to the bladder.
    Mukamel E; Glanz I; Nissenkorn I; Cytron S; Servadio C
    J Urol; 1982 Feb; 127(2):245-6. PubMed ID: 6801270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure associated with the use of thio-tepa.
    Schellhammer PF
    J Urol; 1973 Nov; 110(5):498-501. PubMed ID: 4201562
    [No Abstract]   [Full Text] [Related]  

  • 13. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PIC cystogram: a novel approach to identify "occult" vesicoureteral reflux in children with febrile urinary tract infections.
    Rubenstein JN; Maizels M; Kim SC; Houston JT
    J Urol; 2003 Jun; 169(6):2339-43. PubMed ID: 12771795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 18. First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.
    Heney NM
    Urology; 1985 Oct; 26(4 Suppl):27-9. PubMed ID: 3931325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical treatment with thiotepa: an update review.
    Fosså SD
    Prog Clin Biol Res; 1984; 162B():163-8. PubMed ID: 6438640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of vesico-ureteral reflux with radionuclide or radiographic cystography in children].
    Rantala H; Vorne M; Anttolainen I; Kurri J
    Duodecim; 1981; 97(2):78-83. PubMed ID: 7249965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.